Valsartan/hydrochlorothiazide

From Wikipedia, the free encyclopedia
Valsartan/hydrochlorothiazide
Combination of
Valsartan Angiotensin II receptor antagonist
Hydrochlorothiazide Thiazide diuretic
Clinical data
Trade names co-vasotec
AHFS/Drugs.com FDA Professional Drug Information
MedlinePlus a611032
Licence data US FDA:link
Pregnancy cat. D (US)
Legal status ℞-only (US)
Routes Oral
Identifiers
ATC code C09DA03
PubChem CID 9810581
KEGG D09197 YesY
 YesY (what is this?)  (verify)

Valsartan/hydrochlorothiazide (INNs, trade name Co-vasotec) is an antihypertensive drug combination of an angiotensin II receptor antagonist with hydrochlorothiazide,[1] the most common diuretic to be combined with other blood pressure lowering substances.

See also

  • Discovery and development of angiotensin receptor blockers

References

  1. ↑ Drugs.com: Diovan HCT
Antihypertensives: agents acting on the renin–angiotensin system (C09)
ACE inhibitors
("-pril")
  • Sulfhydryl-containing: Captopril
  • Zofenopril
  • Dicarboxylate-containing: Enalapril#
  • Ramipril
  • Quinapril (+HCT)
  • Perindopril
  • Lisinopril (+HCT)
  • Benazepril
  • Phosphonate-containing: Fosinopril (+HCT)
  • Other/ungrouped: Alacepril
  • Cilazapril
  • Delapril
  • Imidapril
  • Moexipril
  • Rentiapril
  • Spirapril
  • Temocapril
  • Trandolapril
AIIRAs/
("-sartan")
  • Azilsartan
  • Candesartan
  • Eprosartan
  • Irbesartan
  • Losartan (+HCT)
  • Olmesartan (+amlodipine)
  • Tasosartan§
  • Telmisartan (+HCT)
  • Valsartan (+HCT, +amlodipine)
Renin inhibitors/
("-kiren")
  • Aliskiren (+amlodipine, +amlodipine and HCT)
  • Remikiren§
  • #WHO-EM
  • ‡Withdrawn from market
  • Clinical trials:
    • †Phase III
    • §Never to phase III

M: VAS

anat (a:h/u/t/a/l,v:h/u/t/a/l)/phys/devp/cell/prot

noco/syva/cong/lyvd/tumr, sysi/epon, injr

proc, drug (C2s+n/3/4/5/7/8/9)


This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.